XENTRIA

What this means for you

Not registered yet, but its 17 Jan 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99007883

Mark type

Stylized text

Filed

17 Jan 2025

Attorney of record

Eric R. Moran

Goods and services

• Class 005 — Pharmaceuticals: house mark for a full line of biologic, biosimilar, and pharmaceutical preparations; house mark for a full line of biologics; house mark for a full line of biosimilars; house mark for a full line of pharmaceuticals; house mark for a full line of biologic, biosimilar, and pharmaceutical products; biologic, biosimilar, and pharmaceutical preparations for the treatment of bone disease; biologic, biosimilar, and pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; biologic, biosimilar, and pharmaceutical preparations for the treatment of diabetes; biologic, biosimilar, and pharmaceutical preparations for treatment and prevention of autoimmune diseases and autoimmune disorders; biologic, biosimilar, and pharmaceutical oncology preparations; anti-inflammatories; biologic, biosimilar, and pharmaceutical preparations for the treatment of immune system related diseases and disorders; biologic, biosimilar, and pharmaceutical preparations for use in dermatology; biologic, biosimilar, and pharmaceutical preparations for use in rheumatology; biologic, biosimilar, and pharmaceutical preparations, namely, anti-tumor necrosis factor alpha (TNFa) receptor monoclonal antibody for the treatment of disease influenced by TNFa production; biologic, biosimilar, and pharmaceutical preparations, namely, biopharmaceuticals based on human monoclonal antibodies for the treatment of immune and inflammatory diseases and disorders

Owner

• Xentria, Inc., Chicago, IL, US

Prosecution history

• 03 Mar 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 03 Mar 2026 — FINAL REFUSAL E-MAILED
• 03 Mar 2026 — FINAL REFUSAL WRITTEN
• 03 Feb 2026 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
• 07 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 07 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 07 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 08 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 08 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 08 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 08 Jul 2025 — NON-FINAL ACTION E-MAILED
• 08 Jul 2025 — NON-FINAL ACTION WRITTEN
• 27 Jun 2025 — ASSIGNED TO EXAMINER
• 17 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 17 Jan 2025 — NEW APPLICATION ENTERED